Clinical Study
Prevalence and Factors Associated with Vitamin D Deficiency and Hyperparathyroidism in HIV-Infected Patients Treated in Barcelona
Table 2
Risk factors for high levels of PTH (PTH > 65 pg/mL).
| | Univariate analysis | Adjusted analysis | | OR (IC95%) | | OR (IC95%) | |
| Tenofovir exposure | 3.35 (1.86–6.02) | 0.0001 | 3.55 (1.62–7.7) | 0.002 | Vitamin D < 12 ng/mL | 2.2 (1.26–3.82) | 0.007 | 2.14 (1.19–3.82) | 0.01 | Abacavir exposure | 0.48 (0.23–0.98) | 0.04 | 0.87 (0.33–2.31) | 0.7 |
|
|